Advanced search
Publication Cover
Epigenomics Volume 4, 2012 - Issue 2
Submit an article Journal homepage
502
Views
0
CrossRef citations to date
0
Altmetric
Review

Histone-Modifying Enzymes: Regulators of Developmental Decisions and Drivers of Human Disease

Jill S Butler1 Department of Molecular Carcinogenesis at The Virginia Harris Cockrell Cancer Research Center, University of Texas MD Anderson Cancer Center Science Park, PO Box 389, Smithville, TX 78957, USA.;2 Center for Cancer Epigenetics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USAView further author information
,
Evangelia Koutelou1 Department of Molecular Carcinogenesis at The Virginia Harris Cockrell Cancer Research Center, University of Texas MD Anderson Cancer Center Science Park, PO Box 389, Smithville, TX 78957, USA.;2 Center for Cancer Epigenetics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USAView further author information
,
Andria C Schibler1 Department of Molecular Carcinogenesis at The Virginia Harris Cockrell Cancer Research Center, University of Texas MD Anderson Cancer Center Science Park, PO Box 389, Smithville, TX 78957, USA.;2 Center for Cancer Epigenetics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA;3 The Genes & Development Program, Graduate School of Biomedical Sciences, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USAView further author information
&
Sharon YR Dent1 Department of Molecular Carcinogenesis at The Virginia Harris Cockrell Cancer Research Center, University of Texas MD Anderson Cancer Center Science Park, PO Box 389, Smithville, TX 78957, USA.;2 Center for Cancer Epigenetics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA;3 The Genes & Development Program, Graduate School of Biomedical Sciences, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USACorrespondence[email protected]
View further author information
Pages 163-177 | Published online: 27 Mar 2012

References

  • Lessard JA , CrabtreeGR. Chromatin regulatory mechanisms in pluripotency. Annu. Rev. Cell Dev. Biol.26 , 503–532 (2010).
  • Mills AA . Throwing the cancer switch. reciprocal roles of polycomb and trithorax proteins. Nat. Rev. Cancer10(10) , 669–682 (2010).
  • Ringrose L , ParoR. Epigenetic regulation of cellular memory by the polycomb and trithorax group proteins. Annu. Rev. Genet.38 , 413–443 (2004).
  • Soshnikova N , DubouleD. Epigenetic regulation of vertebrate Hox genes: a dynamic equilibrium. Epigenetics4(8) , 537–540 (2009).
  • Mallo M , WellikDM, DeschampsJ. Hox genes and regional patterning of the vertebrate body plan. Dev. Biol.344(1) , 7–15 (2010).
  • Shah N , SukumarS. The Hox genes and their roles in oncogenesis. Nat. Rev. Cancer10(5) , 361–371 (2010).
  • Torres-Padilla ME , ParfittDE, KouzaridesT, Zernicka-GoetzM. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature445(7124) , 214–218 (2007).
  • Wu Q , BruceAW, JedrusikA et al. CARM1 is required in embryonic stem cells to maintain pluripotency and resist differentiation. Stem Cells 27(11) , 2637–2645 (2009).
  • Parfitt DE , Zernicka-GoetzM. Epigenetic modification affecting expression of cell polarity and cell fate genes to regulate lineage specification in the early mouse embryo. Mol. Biol. Cell21(15) , 2649–2660 (2010).
  • O‘neill LP , VermilyeaMD, TurnerBM. Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations. Nat. Genet.38(7) , 835–841 (2006).
  • Ang YS , TsaiSY, LeeDF et al. Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 145(2) , 183–197 (2011).
  • Dou Y , MilneTA, RuthenburgAJ et al. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat. Struct. Mol. Biol. 13(8) , 713–719 (2006).
  • Boyer LA , PlathK, ZeitlingerJ et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441(7091) , 349–353 (2006).
  • Conerly MI , MacquarrieKL, FongAP, YaoZ, TapscottSJ. Polycomb-mediated repression during terminal differentiation: what don‘t you want to be when you grow up? Genes Dev.25(10) , 997–1003 (2011).
  • Lee TI , JennerRG, BoyerLA et al. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125(2) , 301–313 (2006).
  • Lee MG , VillaR, TrojerP et al. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 318(5849) , 447–450 (2007).
  • Agger K , CloosPA, ChristensenJ et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449(7163) , 731–734 (2007).
  • Lan F , BaylissPE, RinnJL et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 449(7163) , 689–694 (2007).
  • Peng JC , ValouevA, SwigutT et al. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 139(7) , 1290–1302 (2009).
  • Pasini D , CloosPA, WalfridssonJ et al. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 464(7286) , 306–310 (2010).
  • Shen X , KimW, FujiwaraY et al. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 139(7) , 1303–1314 (2009).
  • Endoh M , EndoTA, EndohT et al. Polycomb group proteins Ring1A/B are functionally linked to the core transcriptional regulatory circuitry to maintain ES cell identity. Development 135(8) , 1513–1524 (2008).
  • Stock JK , GiadrossiS, CasanovaM et al. Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat. Cell Biol. 9(12) , 1428–1435 (2007).
  • Alder O , LavialF, HelnessA et al. Ring1B and Suv39h1 delineate distinct chromatin states at bivalent genes during early mouse lineage commitment. Development 137(15) , 2483–2492 (2010).
  • Loh YH , ZhangW, ChenX, GeorgeJ, NgHH. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev.21(20) , 2545–2557 (2007).
  • Feldman N , GersonA, FangJ et al. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 8(2) , 188–194 (2006).
  • Epsztejn-Litman S , FeldmanN, Abu-RemailehM et al. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat. Struct. Mol. Biol.15(11) , 1176–1183 (2008).
  • Szutorisz H , CanzonettaC, GeorgiouA, ChowCM, ToraL, DillonN. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage. Mol. Cell Biol.25(5) , 1804–1820 (2005).
  • Pasini D , MalatestaM, JungHR et al. Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res. 38(15) , 4958–4969 (2010).
  • Yao TP , OhSP, FuchsM et al. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93(3) , 361–372 (1998).
  • Xu CR , ColePA, MeyersDJ, KormishJ, DentS, ZaretKS. Chromatin ‘prepattern‘ and histone modifiers in a fate choice for liver and pancreas. Science332(6032) , 963–966 (2011).
  • Ma P , SchultzRM. Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos. Dev. Biol.319(1) , 110–120 (2008).
  • Brunmeir R , LaggerS, SeiserC. Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation. Int. J. Dev. Biol.53(2–3) , 275–289 (2009).
  • Kaji K , NicholsJ, HendrichB. Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells. Development134(6) , 1123–1132 (2007).
  • Marino S , NusseR. Mutants in the mouse NuRD/Mi2 component P66α are embryonic lethal. PLoS ONE2(6) , e519 (2007).
  • Zhu D , FangJ, LiY, ZhangJ. Mbd3, a component of NuRD/Mi-2 complex, helps maintain pluripotency of mouse embryonic stem cells by repressing trophectoderm differentiation. PLoS ONE4(11) , e7684 (2009).
  • Liang J , WanM, ZhangY et al. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 10(6) , 731–739 (2008).
  • Dovey OM , FosterCT, CowleySM. Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc. Natl Acad. Sci. USA107(18) , 8242–8247 (2010).
  • Lyu J , JhoEH, LuW. Smek promotes histone deacetylation to suppress transcription of Wnt target gene brachyury in pluripotent embryonic stem cells. Cell Res.21(6) , 911–921 (2011).
  • Addis RC , PrasadMK, YochemRL et al. OCT3/4 regulates transcription of histone deacetylase 4 (Hdac4) in mouse embryonic stem cells. J. Cell Biochem. 111(2) , 391–401 (2010).
  • Montgomery RL , DavisCA, PotthoffMJ et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev. 21(14) , 1790–1802 (2007).
  • Trivedi CM , LuoY, YinZ et al. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity. Nat. Med. 13(3) , 324–331 (2007).
  • Broide RS , RedwineJM, AftahiN, YoungW, BloomFE, WinrowCJ. Distribution of histone deacetylases 1–11 in the rat brain. J. Mol. Neurosci.31(1) , 47–58 (2007).
  • Akhtar MW , RaingoJ, NelsonED et al. Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function. J. Neurosci. 29(25) , 8288–8297 (2009).
  • Quinti L , ChopraV, RotiliD et al. Evaluation of histone deacetylases as drug targets in Huntington‘s disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model. PLoS Curr. 2 , pii: RRN1172 (2010).
  • Helmlinger D , HardyS, EberlinA, DevysD, ToraL. Both normal and polyglutamine-expanded ataxin-7 are components of TFTC-type GCN5 histone acetyltransferase – containing complexes. Biochem. Soc. Symp.73 , 155–163 (2006).
  • Mcmahon SJ , Pray-GrantMG, SchieltzD, YatesJR 3rd, Grant PA. Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity. Proc. Natl Acad. Sci. USA102(24) , 8478–8482 (2005).
  • Palhan VB , ChenS, PengGH et al. Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. Proc. Natl Acad. Sci. USA 102(24) , 8472–8477 (2005).
  • David G , AbbasN, StevaninG et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat. Genet. 17(1) , 65–70 (1997).
  • David G , DurrA, StevaninG et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum. Mol. Genet. 7(2) , 165–170 (1998).
  • Chen YC , GatchelJR, LewisRW et al. Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model. Hum. Mol. Genet. 21(2) , 394–405 (2012).
  • Caretti G , Di Padova M, Micales B, Lyons Ge, Sartorelli V. The polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev.18(21) , 2627–2638 (2004).
  • Rampalli S , LiL, MakE et al. p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat. Struct. Mol. Biol. 14(12) , 1150–1156 (2007).
  • Acharyya S , SharmaSM, ChengAS et al. TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in duchenne muscular dystrophy. PLoS ONE 5(8) , e12479 (2010).
  • Chen H , GuX, SuIH et al. Polycomb protein Ezh2 regulates pancreatic β-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev. 23(8) , 975–985 (2009).
  • Dhawan S , TschenSI, BhushanA. Bmi-1 regulates the Ink4a/Arf locus to control pancreatic β-cell proliferation. Genes Dev.23(8) , 906–911 (2009).
  • Ezhkova E , PasolliHA, ParkerJS et al. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell 136(6) , 1122–1135 (2009).
  • Leung C , LingbeekM, ShakhovaO et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428(6980) , 337–341 (2004).
  • Roman-Trufero M , Mendez-GomezHR, PerezC et al. Maintenance of undifferentiated state and self-renewal of embryonic neural stem cells by Polycomb protein Ring1B. Stem Cells 27(7) , 1559–1570 (2009).
  • Sher F , RosslerR, BrouwerN, BalasubramaniyanV, BoddekeE, CoprayS. Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2. Stem Cells26(11) , 2875–2883 (2008).
  • Pasini D , BrackenAP, HansenJB, CapilloM, HelinK. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol. Cell Biol.27(10) , 3769–3779 (2007).
  • Hirabayashi Y , SuzkiN, TsuboiM et al. Polycomb limits the neurogenic competence of neural precursor cells to promote astrogenic fate transition. Neuron 63(5) , 600–613 (2009).
  • Luna-Fineman S , ShannonKM, LangeBJ. Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood85(8) , 1985–1999 (1995).
  • Dohner K , BrownJ, HehmannU et al. Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders. Blood 92(11) , 4031–4035 (1998).
  • Iwase S , LanF, BaylissP et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128(6) , 1077–1088 (2007).
  • Kleine-Kohlbrecher D , ChristensenJ, VandammeJ et al. A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation. Mol. Cell 38(2) , 165–178 (2010).
  • Van Bokhoven H , KramerJM. Disruption of the epigenetic code. an emerging mechanism in mental retardation. Neurobiol. Dis.39(1) , 3–12 (2010).
  • Shima Y , KitabayashiI. Deregulated transcription factors in leukemia. Int. J. Hematol.94(2) , 134–141 (2011).
  • Kobelka CE . Exome sequencing: expanding the genetic testing toolbox. Clin. Genet.78(2) , 132–134 (2010).
  • Cooper GM , ShendureJ. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat. Rev. Genet.12(9) , 628–640 (2011).
  • Bamshad MJ , NgSB, BighamAW et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12(11) , 745–755 (2011).
  • Vogelstein B , KinzlerKW. Cancer genes and the pathways they control. Nat. Med.10(8) , 789–799 (2004).
  • Liu H , ChengEH, HsiehJJ. MLL fusions: pathways to leukemia. Cancer Biol. Ther.8(13) , 1204–1211 (2009).
  • Marschalek R . Mechanisms of leukemogenesis by MLL fusion proteins. Br. J. Haematol.152(2) , 141–154 (2010).
  • Guenther MG , LawtonLN, RozovskaiaT et al. Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. Genes Dev. 22(24) , 3403–3408 (2008).
  • Morin RD , Mendez-LagoM, MungallAJ et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476(7360) , 298–303 (2011).
  • Pasqualucci L , TrifonovV, FabbriG et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat. Genet. 43(9) , 830–837 (2011).
  • Hess JL , YuBD, LiB, HansonR, KorsmeyerSJ. Defects in yolk sac hematopoiesis in Mll-null embryos. Blood90(5) , 1799–1806 (1997).
  • Heuser M , YapDB, LeungM et al. Loss of MLL5 results in pleiotropic hematopoietic defects, reduced neutrophil immune function, and extreme sensitivity to DNA demethylation. Blood 113(7) , 1432–1443 (2009).
  • Velichutina I , ShaknovichR, GengH et al. EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood 116(24) , 5247–5255 (2010).
  • Chase A , CrossNC. Aberrations of EZH2 in cancer. Clin. Cancer Res.17(9) , 2613–2618 (2011).
  • Morin RD , JohnsonNA, SeversonTM et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet. 42(2) , 181–185 (2010).
  • Yap DD , ChuJ, BergT et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 117(8) , 2451–2459 (2011).
  • Makishima H , JankowskaAM, TiuRV et al. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia 24(10) , 1799–1804 (2010).
  • Nikoloski G , LangemeijerSM, KuiperRP et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat. Genet. 42(8) , 665–667 (2010).
  • Ernst T , ChaseAJ, ScoreJ et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat. Genet. 42(8) , 722–726 (2010).
  • Jankowska AM , MakishimaH, TiuRV et al. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2 and DNMT3A. Blood 118(14) , 3932–3941 (2011).
  • Grossmann V , KohlmannA, EderC et al. Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance. Leukemia 25(5) , 877–879 (2011).
  • Van Haaften G , DalglieshGL, DaviesH et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet. 41(5) , 521–523 (2009).
  • Chapman MA , LawrenceMS, KeatsJJ et al. Initial genome sequencing and analysis of multiple myeloma. Nature 471(7339) , 467–472 (2011).
  • Stec I , WrightTJ, Van Ommen GJ et al. WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf–Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum. Mol. Genet.7(7) , 1071–1082 (1998).
  • Martinez-Garcia E , PopovicR, MinDJ et al. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood 117(1) , 211–220 (2011).
  • Mullighan CG , ZhangJ, KasperLH et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature471(7337) , 235–239 (2011).
  • Pasqualucci L , Dominguez-SolaD, ChiarenzaA et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471(7337) , 189–195 (2011).
  • Oike Y , TakakuraN, HataA et al. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood 93(9) , 2771–2779 (1999).
  • Parsons DW , LiM, ZhangX et al. The genetic landscape of the childhood cancer medulloblastoma. Science 331(6016) , 435–439 (2011).
  • Northcott PA , NakaharaY, WuX et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat. Genet. 41(4) , 465–472 (2009).
  • Gui Y , GuoG, HuangY et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat. Genet. 43(9) , 875–878 (2011).
  • Dalgliesh GL , FurgeK, GreenmanC et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463(7279) , 360–363 (2010).
  • Varela I , TarpeyP, RaineK et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469(7331) , 539–542 (2011).
  • Petrij F , GilesRH, DauwerseHG et al. Rubinstein–Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376(6538) , 348–351 (1995).
  • Roelfsema JH , PetersDJ. Rubinstein–Taybi syndrome: clinical and molecular overview. Expert Rev. Mol. Med.9(23) , 1–16 (2007).
  • De Sario A . Clinical and molecular overview of inherited disorders resulting from epigenomic dysregulation. Eur. J. Med. Genet.52(6) , 363–372 (2009).
  • Alarcon JM , MalleretG, TouzaniK et al. Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein–Taybi syndrome and its amelioration. Neuron 42(6) , 947–959 (2004).
  • Bartholdi D , RoelfsemaJH, PapadiaF et al. Genetic heterogeneity in Rubinstein–Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300. J. Med. Genet. 44(5) , 327–333 (2007).
  • Miller RW , RubinsteinJH. Tumors in Rubinstein–Taybi syndrome. Am. J. Med. Genet.56(1) , 112–115 (1995).
  • Kleefstra T , SmidtM, BanningMJ et al. Disruption of the gene Euchromatin histone methyl transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome. J. Med. Genet. 42(4) , 299–306 (2005).
  • Verhoeven WM , EggerJI, VermeulenK, Van De Warrenburg BP, Kleefstra T. Kleefstra syndrome in three adult patients: further delineation of the behavioral and neurological phenotype shows aspects of a neurodegenerative course. Am. J. Med. Genet. A155(10) , 2409–2415 (2011).
  • Cheung HC , YatsenkoSA, KadapakkamM et al. Constitutional tandem duplication of 9q34 that truncates EHMT1 in a child with ganglioglioma. Pediatr. Blood Cancer 58(5) , 801–805 (2012).
  • Jensen LR , AmendeM, GurokU et al. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet. 76(2) , 227–236 (2005).
  • Rujirabanjerd S , NelsonJ, TarpeyPS et al. Identification and characterization of two novel JARID1C mutations: suggestion of an emerging genotype-phenotype correlation. Eur. J. Hum. Genet. 18(3) , 330–335 (2010).
  • Tahiliani M , MeiP, FangR et al. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 447(7144) , 601–605 (2007).
  • Ng SB , BighamAW, BuckinghamKJ et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat. Genet. 42(9) , 790–793 (2010).
  • Paulussen AD , StegmannAP, BlokMJ et al. MLL2 mutation spectrum in 45 patients with Kabuki syndrome. Hum. Mutat.32(2) , E2018–E2025 (2010).
  • Hannibal MC , BuckinghamKJ, NgSB et al. Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome. Am. J. Med. Genet. A 155A(7) , 1511–1516 (2011).
  • Li Y , BogershausenN, AlanayY et al. A mutation screen in patients with Kabuki syndrome. Hum. Genet. 130(6) , 715–724 (2011).
  • Niikawa N , MatsuuraN, FukushimaY, OhsawaT, KajiiT. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J. Pediatr.99(4) , 565–569 (1981).
  • Kuroki Y , SuzukiY, ChyoH, HataA, MatsuiI. A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. J. Pediatr.99(4) , 570–573 (1981).
  • Pless B , OehmC, KnauerS, StauberRH, DingermannT, MarschalekR. The heterodimerization domains of MLL-FYRN and FYRC – are potential target structures in t(4;11) leukemia. Leukemia25(4) , 663–670 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.